A lot of the harm from the Schumer-Manchin drug pricing deal received’t grow to be seen for years. However individuals who perceive the business can already foresee it, and one instance is fewer remedy choices for desperately sick most cancers sufferers.
The mooted invoice would empower the secretary of Well being and Human Providers to “negotiate” Medicare drug costs. “They’ve full latitude to principally resolve no matter worth they need the drug to be,” AbbVie CEO Richard Gonzalez stated Friday on an earnings name. “It’s not a negotiation. We should always simply name it what it’s. It’s worth controls.”
